journal article·2026-07-21

From Morphology to Mechanism: Cryo-Electron Microscopy Insights into Lipid Nanoparticles for RNA Delivery

Yulin Mo, Gang Zheng

ACS Nano· Volume 20· Issue 28
Publisher page

Abstract

Lipid nanoparticles (LNPs) have emerged as the leading delivery platform for RNA therapeutics, yet the relationship between their internal structure and biological function remains incompletely understood. Cryogenic electron microscopy (cryo-EM) has revealed a striking diversity of LNP morphologies, but a coherent framework linking structural class to formation mechanism and functional outcome has been lacking. Here, based on cryo-EM evidence, we present a systematic classification of LNP morphologies into monophasic (solid-core, multilamellar, and inverse hexagonal) and biphasic (bleb and liposomal) architectures. For each class, we dissect the mechanistic origins of assembly, explaining how ionizable lipid chemistry, helper lipid geometry, RNA cargo properties, and formulation parameters collectively determine structural outcome, and map the spatial distribution of lipid and nucleic acid components within individual particles. We then evaluate how these structural features affect biological fate, from endosomal membrane fusion and cargo release to protein corona formation and in vivo biodistribution. A central finding across the literature is that equivalent morphology does not always guarantee equivalent biological outcome; the pathway by which a given structure is formed critically shapes its intraparticle molecular organization and, consequently, its transfection efficacy. We further discuss how biological environments, particularly endosomal acidification and protein adsorption, dynamically remodel LNP structure and function. By synthesizing structural, mechanistic, and functional insights, this Review aims to establish the design principles needed to rationally engineer LNP morphology for next-generation RNA therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Lipid Membrane Structure and Behavior · Nuclear Structure and Function

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Princess Margaret Cancer Center

University Health Network

Department of Medical Biophysics, University of Toronto, 101 College Street, Toronto, Ontario M5G 1L7, Canada

Funding

Canadian Institutes of Health Research · Canada Research Chairs · Princess Margaret Cancer Foundation

References (100+)

Show source-provided references
1. 10.1126/scitranslmed.300836210.1126/scitranslmed.3008362 ↗
2. 10.1016/j.cmet.2018.03.00410.1016/j.cmet.2018.03.004 ↗
3. 10.1016/j.jacbts.2022.02.00310.1016/j.jacbts.2022.02.003 ↗
4. 10.1038/s41565-019-0591-y10.1038/s41565-019-0591-y ↗
5. 10.1056/NEJMoa203457710.1056/NEJMoa2034577 ↗
6. 10.1056/NEJMoa210745410.1056/NEJMoa2107454 ↗
7. 10.1056/NEJMoa230914910.1056/NEJMoa2309149 ↗
8. 10.1016/j.omtm.2025.10151810.1016/j.omtm.2025.101518 ↗
9. 10.1021/acsnano.4c1827410.1021/acsnano.4c18274 ↗
10. 10.1038/s41573-024-00977-610.1038/s41573-024-00977-6 ↗
11. 10.1038/s41565-021-00898-010.1038/s41565-021-00898-0 ↗
12. 10.1016/j.addr.2020.06.02610.1016/j.addr.2020.06.026 ↗
13. 10.1021/acs.accounts.9b0036810.1021/acs.accounts.9b00368 ↗
14. 10.1038/s44222-026-00401-110.1038/s44222-026-00401-1 ↗
15. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
16. 10.1021/acsnano.8b0151610.1021/acsnano.8b01516 ↗
17. 10.1038/s41467-024-45666-510.1038/s41467-024-45666-5 ↗
18. 10.1016/j.bpj.2021.03.01210.1016/j.bpj.2021.03.012 ↗
19. 10.1038/s41467-025-58523-w10.1038/s41467-025-58523-w ↗
20. 10.1039/C9NR09347H10.1039/C9NR09347H ↗
21. 10.1073/pnas.231049112010.1073/pnas.2310491120 ↗
22. 10.1073/pnas.231170012010.1073/pnas.2311700120 ↗
23. 10.1002/adma.20230337010.1002/adma.202303370 ↗
24. 10.1021/acs.langmuir.2c0279410.1021/acs.langmuir.2c02794 ↗
25. 10.1073/pnas.230106712010.1073/pnas.2301067120 ↗
26. 10.3390/cells1410071610.3390/cells14100716 ↗
27. 10.1021/jacs.4c1830810.1021/jacs.4c18308 ↗
28. 10.1021/acsami.4c2007710.1021/acsami.4c20077 ↗
29. 10.1016/j.jconrel.2025.11387910.1016/j.jconrel.2025.113879 ↗
30. 10.1039/f2976720152510.1039/f29767201525 ↗
31. 10.1038/sj.gt.330150610.1038/sj.gt.3301506 ↗
32. 10.1016/S0169-409X(01)00103-X10.1016/S0169-409X(01)00103-X ↗
33. 10.1155/2015/15168310.1155/2015/151683 ↗
34. 10.1021/acs.jpcb.5b0289110.1021/acs.jpcb.5b02891 ↗
35. 10.1021/acs.langmuir.2c0149210.1021/acs.langmuir.2c01492 ↗
36. 10.1021/acs.jpcb.7b1079510.1021/acs.jpcb.7b10795 ↗
37. 10.1002/smll.20230920010.1002/smll.202309200 ↗
38. 10.1038/s41467-025-60380-610.1038/s41467-025-60380-6 ↗
39. 10.1016/j.jcis.2026.13996610.1016/j.jcis.2026.139966 ↗
40. 10.1002/smll.20250223110.1002/smll.202502231 ↗
41. 10.1021/acsnano.3c0118610.1021/acsnano.3c01186 ↗
42. 10.1002/advs.20241301610.1002/advs.202413016 ↗
43. 10.1073/pnas.230780012010.1073/pnas.2307800120 ↗
44. 10.1016/j.celbio.2025.10033910.1016/j.celbio.2025.100339 ↗
45. 10.1038/s42003-021-02441-210.1038/s42003-021-02441-2 ↗
46. 10.1021/acs.molpharmaceut.2c0058710.1021/acs.molpharmaceut.2c00587 ↗
47. 10.1016/j.jconrel.2023.03.03910.1016/j.jconrel.2023.03.039 ↗
48. 10.1021/acsnano.4c1409810.1021/acsnano.4c14098 ↗
49. 10.1021/acsnano.5c0980010.1021/acsnano.5c09800 ↗
50. 10.1021/acs.molpharmaceut.2c0009210.1021/acs.molpharmaceut.2c00092 ↗
51. 10.1016/j.jconrel.2024.07.04610.1016/j.jconrel.2024.07.046 ↗
52. 10.1021/acs.nanolett.0c0138610.1021/acs.nanolett.0c01386 ↗
53. 10.1002/smll.20240081510.1002/smll.202400815 ↗
54. 10.1002/adma.20231087210.1002/adma.202310872 ↗
55. 10.1016/j.cej.2025.15931810.1016/j.cej.2025.159318 ↗
56. 10.1038/s41598-025-21880-z10.1038/s41598-025-21880-z ↗
57. 10.1016/j.omtn.2019.01.01310.1016/j.omtn.2019.01.013 ↗
58. 10.1002/anie.20120326310.1002/anie.201203263 ↗
59. 10.1021/acs.molpharmaceut.4c0042610.1021/acs.molpharmaceut.4c00426 ↗
60. 10.3390/pharmaceutics1606077110.3390/pharmaceutics16060771 ↗
61. 10.1021/acsnano.3c0801410.1021/acsnano.3c08014 ↗
62. Israelachvili J. N. · 2011
63. 10.1002/adhm.20240125210.1002/adhm.202401252 ↗
64. Bethiana, T.; Aljabbari, A.; Li, Y.; Mitra, H.; Baghbanbashi, M.; Harris, G.; Dasaro, S. R.; Masoomi, F.; Vago, F. S.; Hartzler, S. L.; Figueiredo, M.; Metskas, L. A.; Vlachos, P.; Ardekani, A.; Yeo, Y.; Ristroph, K. Identifying Differential Effects from Eleven Mixing Techniques on mRNA Lipid Nanoparticle Physicochemistry and Biological Performance bioRxiv 2025 https://www.biorxiv.org/content/10.1101/2025.11.07.687311v1.full. (accessed June 09, 2026).10.1101/2025.11.07.687311 ↗
65. 10.1038/s41598-023-43898-x10.1038/s41598-023-43898-x ↗
66. 10.1016/j.jconrel.2024.07.05210.1016/j.jconrel.2024.07.052 ↗
67. 10.1002/advs.20251163710.1002/advs.202511637 ↗
68. 10.1021/acs.molpharmaceut.3c0095610.1021/acs.molpharmaceut.3c00956 ↗
69. 10.1016/j.ijpharm.2024.12494210.1016/j.ijpharm.2024.124942 ↗
70. 10.3390/pharmaceutics1801005010.3390/pharmaceutics18010050 ↗
71. 10.1016/j.omtm.2023.06.00510.1016/j.omtm.2023.06.005 ↗
72. 10.1016/j.jconrel.2026.11464010.1016/j.jconrel.2026.114640 ↗
73. 10.1002/smtd.20240062210.1002/smtd.202400622 ↗
74. 10.1016/j.omtm.2025.10157810.1016/j.omtm.2025.101578 ↗
75. 10.1039/C9NR02004G10.1039/C9NR02004G ↗
76. 10.1021/acsnano.2c1093610.1021/acsnano.2c10936 ↗
77. 10.1002/anie.20230497710.1002/anie.202304977 ↗
78. 10.1021/acsnano.2c0621310.1021/acsnano.2c06213 ↗
79. 10.1021/acs.molpharmaceut.4c0123910.1021/acs.molpharmaceut.4c01239 ↗
80. 10.1021/acs.jctc.5c0049810.1021/acs.jctc.5c00498 ↗
81. 10.1021/acsnano.4c0451910.1021/acsnano.4c04519 ↗
82. 10.1021/acs.bioconjchem.0c0036610.1021/acs.bioconjchem.0c00366 ↗
83. 10.1021/acsnano.0c1006410.1021/acsnano.0c10064 ↗
84. 10.1039/D0BM01609H10.1039/D0BM01609H ↗
85. 10.1021/la203290a10.1021/la203290a ↗
86. 10.1073/pnas.132293711110.1073/pnas.1322937111 ↗
87. 10.1021/acs.molpharmaceut.2c0044210.1021/acs.molpharmaceut.2c00442 ↗
88. 10.1038/s41565-024-01847-310.1038/s41565-024-01847-3 ↗
89. 10.1073/pnas.230780312010.1073/pnas.2307803120 ↗
90. Grumelot S. · bioRxiv · 2025
91. 10.1021/jacs.5c1602510.1021/jacs.5c16025 ↗
92. 10.1021/acsnano.5c1155210.1021/acsnano.5c11552 ↗
93. 10.1038/s41467-020-14527-210.1038/s41467-020-14527-2 ↗
94. 10.1002/advs.20241652510.1002/advs.202416525 ↗
95. 10.1038/s41467-025-63726-210.1038/s41467-025-63726-2 ↗
96. 10.1039/C9NR05788A10.1039/C9NR05788A ↗
97. 10.1021/acsami.5c1705210.1021/acsami.5c17052 ↗
98. 10.1016/j.ijpx.2025.10044110.1016/j.ijpx.2025.100441 ↗
99. 10.1002/adhm.20220270910.1002/adhm.202202709 ↗
100. 10.1016/j.biomaterials.2025.12367110.1016/j.biomaterials.2025.123671 ↗